Cargando…

Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study

CONTEXT: Clinically nonfunctioning pituitary adenomas (CNFPAs) typically remain undetected until mass effect symptoms develop. However, currently, head imaging is performed commonly for many other indications, which may increase incidental discovery of CNFPAs. Since current presentation and outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Freda, Pamela U, Bruce, Jeffrey N, Khandji, Alexander G, Jin, Zhezhen, Hickman, Richard A, Frey, Emily, Reyes-Vidal, Carlos, Otten, Marc, Wardlaw, Sharon L, Post, Kalmon D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101088/
https://www.ncbi.nlm.nih.gov/pubmed/32258955
http://dx.doi.org/10.1210/jendso/bvaa021
_version_ 1783511547297923072
author Freda, Pamela U
Bruce, Jeffrey N
Khandji, Alexander G
Jin, Zhezhen
Hickman, Richard A
Frey, Emily
Reyes-Vidal, Carlos
Otten, Marc
Wardlaw, Sharon L
Post, Kalmon D
author_facet Freda, Pamela U
Bruce, Jeffrey N
Khandji, Alexander G
Jin, Zhezhen
Hickman, Richard A
Frey, Emily
Reyes-Vidal, Carlos
Otten, Marc
Wardlaw, Sharon L
Post, Kalmon D
author_sort Freda, Pamela U
collection PubMed
description CONTEXT: Clinically nonfunctioning pituitary adenomas (CNFPAs) typically remain undetected until mass effect symptoms develop. However, currently, head imaging is performed commonly for many other indications, which may increase incidental discovery of CNFPAs. Since current presentation and outcome data are based on older, retrospective series, a prospective characterization of a contemporary CNFPA cohort was needed. OBJECTIVE: To determine the prevalence of incidental presentation and hypopituitarism and its predictors in a CNFPA cohort that spanned 6 to 9 mm micro- to macroadenoma included observational and surgical therapy. METHODS: At enrollment in a prospective, observational study, 269 patients with CNFPAs were studied by history, examination, blood sampling, and pituitary imaging analysis and categorized into incidental or symptoms presentation groups that were compared. RESULTS: Presentation was incidental in 48.7% of patients and due to tumor symptoms in 51.3%. In the symptoms and incidental groups, 58.7% and 27.4% of patients had hypopituitarism, respectively, and 25% of patients with microadenomas had hypopituitarism. Many had unappreciated signs and symptoms of pituitary disease. Most tumors were macroadenomas (87%) and were larger in the symptoms than incidental and hypopituitary groups than in the eupituitary groups. The patients in the incidental group were older, and males were older and had larger tumors in both the incidental and symptoms groups. CONCLUSIONS: Patients with CNFPAs commonly present incidentally and with previously unrecognized hypopituitarism and symptoms that could have prompted earlier diagnosis. Our data support screening all large micro and macro-CNFPAs for hypopituitarism. Most patients with CNFPAs still have mass effect signs at presentation, suggesting the need for more awareness of pituitary disease. Our ongoing, prospective observation of this cohort will assess outcomes of these CNFPA groups.
format Online
Article
Text
id pubmed-7101088
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71010882020-04-01 Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study Freda, Pamela U Bruce, Jeffrey N Khandji, Alexander G Jin, Zhezhen Hickman, Richard A Frey, Emily Reyes-Vidal, Carlos Otten, Marc Wardlaw, Sharon L Post, Kalmon D J Endocr Soc Clinical Research Article CONTEXT: Clinically nonfunctioning pituitary adenomas (CNFPAs) typically remain undetected until mass effect symptoms develop. However, currently, head imaging is performed commonly for many other indications, which may increase incidental discovery of CNFPAs. Since current presentation and outcome data are based on older, retrospective series, a prospective characterization of a contemporary CNFPA cohort was needed. OBJECTIVE: To determine the prevalence of incidental presentation and hypopituitarism and its predictors in a CNFPA cohort that spanned 6 to 9 mm micro- to macroadenoma included observational and surgical therapy. METHODS: At enrollment in a prospective, observational study, 269 patients with CNFPAs were studied by history, examination, blood sampling, and pituitary imaging analysis and categorized into incidental or symptoms presentation groups that were compared. RESULTS: Presentation was incidental in 48.7% of patients and due to tumor symptoms in 51.3%. In the symptoms and incidental groups, 58.7% and 27.4% of patients had hypopituitarism, respectively, and 25% of patients with microadenomas had hypopituitarism. Many had unappreciated signs and symptoms of pituitary disease. Most tumors were macroadenomas (87%) and were larger in the symptoms than incidental and hypopituitary groups than in the eupituitary groups. The patients in the incidental group were older, and males were older and had larger tumors in both the incidental and symptoms groups. CONCLUSIONS: Patients with CNFPAs commonly present incidentally and with previously unrecognized hypopituitarism and symptoms that could have prompted earlier diagnosis. Our data support screening all large micro and macro-CNFPAs for hypopituitarism. Most patients with CNFPAs still have mass effect signs at presentation, suggesting the need for more awareness of pituitary disease. Our ongoing, prospective observation of this cohort will assess outcomes of these CNFPA groups. Oxford University Press 2020-02-18 /pmc/articles/PMC7101088/ /pubmed/32258955 http://dx.doi.org/10.1210/jendso/bvaa021 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Research Article
Freda, Pamela U
Bruce, Jeffrey N
Khandji, Alexander G
Jin, Zhezhen
Hickman, Richard A
Frey, Emily
Reyes-Vidal, Carlos
Otten, Marc
Wardlaw, Sharon L
Post, Kalmon D
Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study
title Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study
title_full Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study
title_fullStr Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study
title_full_unstemmed Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study
title_short Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study
title_sort presenting features in 269 patients with clinically nonfunctioning pituitary adenomas enrolled in a prospective study
topic Clinical Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101088/
https://www.ncbi.nlm.nih.gov/pubmed/32258955
http://dx.doi.org/10.1210/jendso/bvaa021
work_keys_str_mv AT fredapamelau presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy
AT brucejeffreyn presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy
AT khandjialexanderg presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy
AT jinzhezhen presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy
AT hickmanricharda presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy
AT freyemily presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy
AT reyesvidalcarlos presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy
AT ottenmarc presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy
AT wardlawsharonl presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy
AT postkalmond presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy